Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus cryotherapy for symptomatic cervical ectropion
IRCT20220115053719N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of tranexamic acid in Cervical ectopy (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Pelvic pain. Started Mar 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Cervical ectopy
Beyond the preview
Go deeper on IRCT20220115053719N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220115053719N1.